Vivendal Comp 160 mg/12,5 mg Filmdragerad tablett

Riik: Rootsi

keel: rootsi

Allikas: Läkemedelsverket (Medical Products Agency)

Osta kohe

Infovoldik Infovoldik (PIL)
22-04-2018
Toote omadused Toote omadused (SPC)
22-04-2018

Toimeaine:

hydroklortiazid; valsartan

Saadav alates:

Sandoz A/S

ATC kood:

C09DA03

INN (Rahvusvaheline Nimetus):

hydrochlorothiazide; valsartan

Annus:

160 mg/12,5 mg

Ravimvorm:

Filmdragerad tablett

Koostis:

valsartan 160 mg Aktiv substans; hydroklortiazid 12,5 mg Aktiv substans

Klass:

Apotek

Retsepti tüüp:

Receptbelagt

Terapeutiline ala:

Valsartan och diuretika

Toote kokkuvõte:

Förpacknings: Blister, 7 tabletter (plast/Al); Blister, 7 tabletter (Al); Blister, 10 tabletter (Al); Blister, 14 tabletter (Al); Blister, 15 tabletter (Al); Blister, 20 tabletter (Al); Blister, 28 tabletter (Al); Blister, 30 tabletter (Al); Blister, 50 tabletter (Al); Blister, 56 tabletter (Al); Blister, 60 tabletter (Al); Blister, 84 tabletter (Al); Blister, 90 tabletter (Al); Blister, 98 tabletter (Al); Blister, 100 tabletter (Al); Blister, 280 tabletter (Al); Blister, 10 tabletter (plast/Al); Blister, 14 tabletter (plast/Al); Blister, 15 tabletter (plast/Al); Blister, 20 tabletter (plast/Al); Blister, 28 tabletter (plast/Al); Blister, 30 tabletter (plast/Al); Blister, 50 tabletter (plast/Al); Blister, 56 tabletter (plast/Al); Blister, 60 tabletter (plast/Al); Blister, 84 tabletter (plast/Al); Blister, 90 tabletter (plast/Al); Blister, 98 tabletter (plast/Al); Blister, 100 tabletter (plast/Al); Blister, 280 tabletter (plast/Al); Blister, 50 x 1 tabletter, endos (Al); Blister, 50 x 1 tabletter, endos (plast/Al)

Volitamisolek:

Godkänd

Loa andmise kuupäev:

2011-04-15

Infovoldik

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
Vivendal Comp 80 mg /12.5 mg film-coated tablets
Vivendal Comp 160 mg /12.5 mg film-coated tablets
Vivendal Comp 160 mg /25 mg film-coated tablets
Vivendal Comp 320 mg /12.5 mg film-coated tablets
Vivendal Comp 320 mg /25 mg film-coated tablets
Valsartan/hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Vivendal Comp is and what it is used for
2.
What you need to know before you take Vivendal Comp
3.
How to take Vivendal Comp
4.
Possible side effects
5.
How to store Vivendal Comp
6.
Contents of the pack and other information
1.
WHAT VIVENDAL COMP IS AND WHAT IT IS USED FOR
Vivendal Comp film-coated tablets contain two active substances called
valsartan and
hydrochlorothiazide. Both of these substances help to control high
blood pressure (hypertension).

VALSARTAN belongs to a class of medicines known as “angiotensin II
receptor antagonists”,
which help to control high blood pressure. Angiotensin II is a
substance in the body that
causes vessels to tighten, thus causing your blood pressure to
increase. Valsartan works by
blocking the effect of angiotensin II. As a result, blood vessels
relax and blood pressure is
lowered.

HYDROCHLOROTHIAZIDE belongs to a group of medicines called thiazide
diuretics (also
known as “water tablets”). Hydrochlorothiazide increases urine
output, which also lowers
blood pressure.
Vivendal Comp is used to treat high blood pressure which is not
adequately controlled by a single
substance a
                                
                                Lugege kogu dokumenti
                                
                            

Toote omadused

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik inglise 18-03-2022
Toote omadused Toote omadused inglise 16-01-2019
Avaliku hindamisaruande Avaliku hindamisaruande inglise 21-02-2013